Compare Neurocrine Biosciences Inc (NBIX) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Neurocrine Biosciences Inc trades at $155.5 (market cap $15.77B), while Direxion Daily TSLA Bull 2X Shares trades at $9.75. The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| NBIX | TSLL | |
|---|---|---|
Market Cap | $15.77B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $185.50 | $23.03 |
52-Week Low | $123.10 | $6.74 |
Enterprise Value | $15.78B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Neurocrine Biosciences (NBIX) trades at $155.13, down 0.33% with a bearish technical signal. The company maintains strong fundamentals with 97.91% gross margins and 20.91% net income margin, supported by robust Ingrezza sales growth and Crenessity momentum. Recent news highlights institutional buying interest but also safety concerns around Vykat XR, contributing to recent price volatility.
NBIX presents a compelling growth story with strong profitability and analyst support (86% buy rating), though execution risks and drug safety issues warrant caution. The consensus price target of $207.07 suggests 33% upside potential, making it attractive for investors comfortable with biopharma volatility.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, has surged 7.87% to $9.87, driven by investor enthusiasm ahead of Tesla's Cybercab event. Technical indicators show a bullish trend with strong moving average signals, while oscillators remain neutral. The ETF provides 2x leveraged exposure to Tesla's daily performance, amplifying both gains and losses in one of the market's most volatile stocks.
The outlook remains tied to Tesla's execution, with the Cybercab event serving as a near-term catalyst. However, the leveraged structure poses significant volatility risks, particularly during earnings periods. Investors should be aware that leveraged ETFs can underperform over time due to daily rebalancing effects, making them more suitable for short-term trading than long-term holding.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
